These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 8619397

  • 21. Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome.
    Henderson N, Key NS, Christie B, Kisiel W, Foster D, Nelsestuen GL.
    Thromb Haemost; 2002 Jul; 88(1):98-103. PubMed ID: 12152685
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL, Triplett DA.
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA, Kirby EP, Gentry RD.
    Thromb Haemost; 1981 Aug 28; 46(2):485-8. PubMed ID: 6795739
    [Abstract] [Full Text] [Related]

  • 30. A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C).
    Yatuv R, Dayan I, Baru M.
    Haemophilia; 2006 May 28; 12(3):253-7. PubMed ID: 16643210
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Acquired hemophilia A as a cause of postoperative bleeding].
    Leimkühler K, Bach F, Kobert K, Korth M, Schmidt B, Kulbe C, Gummelt I, Mertzlufft F.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 May 28; 38(5):359-65. PubMed ID: 12712401
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P, Boutière B, Horellou MH, Trzeciak MC, Samama MM.
    Thromb Haemost; 1998 Jul 28; 80(1):104-8. PubMed ID: 9684794
    [Abstract] [Full Text] [Related]

  • 38. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS, Kitchen S, Purdy G, Mackie IJ, Preston FE, Machin SJ.
    Clin Lab Haematol; 1998 Jun 28; 20(3):179-86. PubMed ID: 9681235
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.